The Claim
Polygenic risk scores for C-reactive protein, derived from European populations, exhibit poor predictive validity for inflammation in African American and Hispanic older adults due to differences in genetic architecture and ancestry-specific allele frequencies.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Polygenic risk scores for C-reactive protein developed using European genetic data do not accurately predict inflammation levels in older African American and Hispanic individuals because of genetic differences between populations.
See the scientific wording
Polygenic risk scores for C-reactive protein derived from European populations show poor predictive validity for inflammation in African American and Hispanic older adults, likely due to differences in genetic architecture and ancestry-specific allele frequencies.
Genetic variants that influence C-reactive protein levels differ in frequency and combination between populations, so scores built using European DNA miss the right variants or misweight them in other groups, leading to inaccurate inflammation predictions.
What the research says
1 studyStudy: Associations among discrimination, genetic susceptibility to inflammation, and C-reactive protein
Genetic scores made from white people’s DNA don’t work well to predict inflammation in Black or Hispanic older adults because their genes are different in ways that make those scores misleading.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.